LifeScan has received FDA approval for its OneTouch Verio Synch system, which is used to monitor blood glucose in diabetes patients. The technology uses Bluetooth connectivity to allow patients to wirelessly receive personalized data, including a 14-day summary of glucose test outcomes, via an iPad, iPhone or iPod touch.
FDA OKs Bluetooth-enabled blood glucose monitor from LifeScan
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||